Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001933414-26-000084
Filing Date
2026-05-06
Accepted
2026-05-06 17:15:41
Documents
55
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mlys-20260331.htm   iXBRL 10-Q 550839
2 EX-10.1 mlys2026q110qex101.htm EX-10.1 25161
3 EX-31.1 mlys2026q110qex311.htm EX-31.1 9697
4 EX-31.2 mlys2026q110qex312.htm EX-31.2 9634
5 EX-32.1 mlys2026q110qex321.htm EX-32.1 4984
6 EX-32.2 mlys2026q110qex322.htm EX-32.2 4888
12 mlys-20260331_g1.jpg GRAPHIC 478436
  Complete submission text file 0001933414-26-000084.txt   4489246

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mlys-20260331.xsd EX-101.SCH 26169
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mlys-20260331_cal.xml EX-101.CAL 31175
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mlys-20260331_def.xml EX-101.DEF 111568
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mlys-20260331_lab.xml EX-101.LAB 360518
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mlys-20260331_pre.xml EX-101.PRE 246988
59 EXTRACTED XBRL INSTANCE DOCUMENT mlys-20260331_htm.xml XML 308486
Mailing Address 150 N. RADNOR CHESTER RD. SUITE F200 RADNOR PA 19087
Business Address 150 N. RADNOR CHESTER RD. SUITE F200 RADNOR PA 19087 (888) 378-6240
Mineralys Therapeutics, Inc. (Filer) CIK: 0001933414 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41614 | Film No.: 26949704
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)